USA-based biotechnology company Solexa says that it has reached several milestones in the development of its Genome Analysis System, including the achievement of a 1 gigabase per flow read which, it says, is the first platform to hit this critical level of data output. The company also revealed that it has already shipped 13 systems to customers in five countries, which allowed it to further develop its field support operations.
Solexa's chief executive officer, John West, said: "we believe that the Solexa Genome Analysis System is delivering on its promise to enable researchers worldwide to resequence whole human genomes at a fraction of the cost and time required by other platforms."
Definitive merger deal agreed
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze